These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20430261)

  • 1. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure.
    Gao R; Zhang J; Cheng L; Wu X; Dong W; Yang X; Li T; Liu X; Xu Y; Li X; Zhou M
    J Am Coll Cardiol; 2010 May; 55(18):1907-14. PubMed ID: 20430261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST).
    Yao W; Cheang I; Liao S; Zhou Y; Zhou F; Xu D; Jia Z; Chang L; Zhang H; Li X
    BMC Complement Med Ther; 2020 Feb; 20(1):38. PubMed ID: 32024496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Thiamine Supplementation in the Treatment of Chronic Heart Failure: An Updated Meta-Analysis of Randomized Controlled Trials.
    He S; Wang S; Xu T; Wang S; Qi M; Chen Q; Lin L; Wu H; Gan P
    Clin Cardiol; 2024 Jul; 47(7):e24309. PubMed ID: 38940395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome).
    Wang X; Zhao Z; Mao J; Du T; Chen Y; Xu H; Liu N; Wang X; Wu J; Li R; Xu Y; Zhao Y; Wang L; He J; Zhang J; Zhai J; Zhao G; Hou Y; Wang S; Liu C
    Evid Based Complement Alternat Med; 2019; 2019():9297163. PubMed ID: 30930952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre-Cardiogenic Shock.
    Metra M; Chioncel O; Davison B; Filippatos G; Mebazaa A; Pagnesi M; Adamo M; Novosadova M; Ponikowski P; Simmons P; Soffer J; Simonson S; Cotter G
    J Card Fail; 2023 Jul; 29(7):1097-1103. PubMed ID: 37075941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses.
    Jabbour A; Hayward CS; Keogh AM; Kotlyar E; McCrohon JA; England JF; Amor R; Liu X; Li XY; Zhou MD; Graham RM; Macdonald PS
    Eur J Heart Fail; 2011 Jan; 13(1):83-92. PubMed ID: 20810473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin-1/ErbB signaling and chronic heart failure.
    Xu Y; Li X; Liu X; Zhou M
    Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Min YW; Min BH; Kim S; Choi D; Rhee PL
    PLoS One; 2015; 10(9):e0138927. PubMed ID: 26402448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-remodeling and anti-fibrotic effects of the neuregulin-1β glial growth factor 2 in a large animal model of heart failure.
    Galindo CL; Kasasbeh E; Murphy A; Ryzhov S; Lenihan S; Ahmad FA; Williams P; Nunnally A; Adcock J; Song Y; Harrell FE; Tran TL; Parry TJ; Iaci J; Ganguly A; Feoktistov I; Stephenson MK; Caggiano AO; Sawyer DB; Cleator JH
    J Am Heart Assoc; 2014 Oct; 3(5):e000773. PubMed ID: 25341890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of albiglutide, a GLP-1 receptor agonist.
    Young MA; Wald JA; Matthews JE; Scott R; Hodge RJ; Zhi H; Reinhardt RR
    Postgrad Med; 2014 Nov; 126(7):84-97. PubMed ID: 25387217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability and pharmacokinetics of dalcetrapib following single and multiple ascending doses in healthy subjects: a randomized, double-blind, placebo-controlled, phase I study.
    Derks M; Anzures-Cabrera J; Turnbull L; Phelan M
    Clin Drug Investig; 2011; 31(5):325-35. PubMed ID: 21366361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential.
    Jay SM; Murthy AC; Hawkins JF; Wortzel JR; Steinhauser ML; Alvarez LM; Gannon J; Macrae CA; Griffith LG; Lee RT
    Circulation; 2013 Jul; 128(2):152-61. PubMed ID: 23757312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction.
    Hill MF; Patel AV; Murphy A; Smith HM; Galindo CL; Pentassuglia L; Peng X; Lenneman CG; Odiete O; Friedman DB; Kronenberg MW; Zheng S; Zhao Z; Song Y; Harrell FE; Srinivas M; Ganguly A; Iaci J; Parry TJ; Caggiano AO; Sawyer DB
    PLoS One; 2013; 8(2):e55741. PubMed ID: 23437060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
    Jiang M; Zhang H; Jiang Y; Yang Q; Xie L; Liu W; Zhang W; Ji X; Li P; Chen N; Zhao S; Wang F; Zou L
    Cancer; 2012 Jul; 118(13):3294-301. PubMed ID: 22139825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase.
    Jiang Q; Xu LP; Liu DH; Liu KY; Chen SS; Jiang B; Jiang H; Chen H; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Lai YY; Huang XJ
    Blood; 2011 Mar; 117(11):3032-40. PubMed ID: 21252092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of neuregulin-1 in cardiovascular disease.
    Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
    Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; Castro-Chaves P; Lourenço AP; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2016 Jan; 109(1):44-54. PubMed ID: 26503987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-dependent leukocyte activation in patients with type 2 diabetes mellitus, familial combined hyperlipidemia and healthy controls.
    de Vries MA; Alipour A; Klop B; van de Geijn GJ; Janssen HW; Njo TL; van der Meulen N; Rietveld AP; Liem AH; Westerman EM; de Herder WW; Cabezas MC
    Metabolism; 2015 Feb; 64(2):213-7. PubMed ID: 25456098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetic studies of abiraterone acetate in men with hepatic or renal impairment.
    Marbury T; Lawitz E; Stonerock R; Gonzalez M; Jiao J; Breeding J; Haqq C; Verboven P; Stieltjes H; Yu M; Molina A; Acharya M; Chien C; Tran N
    J Clin Pharmacol; 2014 Jul; 54(7):732-41. PubMed ID: 24374856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuregulin as a heart failure therapy and mediator of reverse remodeling.
    Galindo CL; Ryzhov S; Sawyer DB
    Curr Heart Fail Rep; 2014 Mar; 11(1):40-9. PubMed ID: 24234399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.